Radar › Companies › Healthcare · Boston
Radar · Healthcare in Boston

Best Healthcare Companies in Boston, United States

The 314 best Healthcare companies in Boston, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ziopharm Oncology.

314companies tracked
$3.2Bdisclosed funding
0unicorns
88have raised

Ranked: Best Healthcare companies in Boston

#CompanyDisclosed fundingLast roundEmployeesFoundedFounderTech stackPatents & IP focusRecent signals
1Ziopharm Oncology
Develops immunotherapies for the treatment of cancer and autoimmune diseases
$377M81 mo ago362003Kevin Boyle
CEO
—160 patents
Isophosphoramide mustard salt prodrugs for oral cancer therapy, especially glioblastoma.
—
2Ventus Therapeutics
Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment
$300M52 mo ago762019——152 patents
Small‑molecule inhibitors of NLRP3 inflammasome and related caspase pathways
—
3Centessa Pharmaceuticals
Developer of therapeutic programs addressing unmet needs in various disease areas
$250M64 mo ago83
83 → 157 (+89%)
2021—WordPressApple iCloud MailMicrosoft 365+31——
4Aiolos Bio
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
$245M31 mo ago—2023Elizabeth Holt
Founder and VP
———
5Blue Rock Therapeutics
Stem cell therapies for cardiovascular and neurological diseases
$225M114 mo ago1382016—WordPressApple iCloud MailMySQL+22——
6Jnana Therapeutics
Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters
$207M43 mo ago102017Joanne Kotz
Co-Founder & President
———
7Parallel
Developer of cannabis based products focused on well being
$175M42 mo ago1,7002014William Wrigley
CEO
WebflowApple iCloud MailMicrosoft 365+1537 patents
Healthcare data management and analytics platforms for clinical sites and digital content.
—
8Superluminal Medicines
Generative biological and chemical company focused on drug discovery
57Funding top 21%Talent top 38%Market bottom 44%Partners bottom 35%
All 6 signals ▾
Fundingtop 21%
Talenttop 38%
Marketbottom 44%
Partnersbottom 35%
Globalbottom 29%
Newsbottom 15%
Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
rank vs industry peers · Fliar Intelligence Index 57/100
$153M10 mo ago—2022Ajay Yekkirala
Co-Founder
———
9Pieris Pharmaceuticals
Therapeutics based on recombinant engineered lipocalin mimics
$119M59 mo ago1272001————
10SAGE Therapeutics
Developer of drug candidates for the treatment of rare CNS disorders
$106M65 mo ago4871971Barry Greene
CEO
WordPressDrupalApple iCloud Mail+281,810 patents
Neuroactive steroid compounds and formulations for treating central nervous system disorders
—
11Imbria Pharmaceuticals
Provider of therapeutics solution by translation the cellular metabolism
$90M7 mo ago42014David-Alexandre Gros
Co-Founder & CEO
—161 patents
Metabolic-modulating small molecules for cardiac, renal, and fibrotic disease therapy
—
12Mercy BioAnalytics
Manufacturer of diagnostic test devices
$68M9 mo ago182018Joseph Sedlak
Co-Founder & CSO
—87 patents
Molecular diagnostic assays and biomarkers for early cancer detection
2 job openings · 2 launchs
13GALY
Provider of medical research labs
$62M23 mo ago222018Luciano Bueno
Founder & CEO
ContentfulApple iCloud MailMicrosoft 365+1527 patents
Biotech methods for in vitro cotton fiber production and plant cell culture
1 job opening
14Lusaris Therapeutics
Provider of neuropsychiatric treatment services
$60M43 mo ago52021Ed Monaghan
Co-Founder & CDO
———
15NextRNA
Developer of RNA-targeted therapeutics for multiple areas
$56M51 mo ago322020Leon Lamas
Co-Founder
———
16InStride Health
Provider of anxiety management & therapy services
$56M26 mo ago852021Mona Potter
Co-Founder
WordPressMySQLZoho+22——
17Restorbio
Reviews beauty products, ingredients, and promotes informed skincare, hair, and body choices
$40M102 mo ago252016——4 patents
Pharmaceutical combination therapies and immune‑enhancing drug formulations
—
18TigaTx
Provider of cancer drugs development services
$37M18 mo ago32018Anne Altmeyer
CEO
—24 patents
Therapeutic antibody engineering for oncology, focusing on CD20, IgA, anti‑GD2 and bispecific T‑cell engagers
—
19General Fluidics
Vitro diagnostic company
$35M23 mo ago142011Robert Granier
CEO
——1 partnership
20Peplib
Provider of peptide drug discovery and development services for global pharmaceutical industries
$34M61 mo ago72017Li Sean
Co-Founder
——4 job openings
21Animol Discovery
R&D company focused on manufacturing drugs for multiple therapeutic areas
$34M17 mo ago202019Philip Austin
Co-founder and Member of Board of Directors
—11 patents
Veterinary drugs: canine JAK inhibitors and antiparasitic cyclic depsipeptide therapeutics.
—
22Aliada Therapeutics
Provider of drug research & development services for multiple therapeutic areas
$33M59 mo ago182021————
23Grouper
Provider of fitness services
$29M9 mo ago—2018Spencer Morgan
Founder
WordPressApple iCloud MailGoogle Workspace+24——
24PIH
Health organization aims to fights social injustice by bringing the benefits of modern medical science
$25M16 mo ago3351987Ophelia Dahl
Co-Founder
DrupalPHPJava+39——
25Clinton Health Access Initiative
Healthcare foundation focused on dedicated to saving lives of patients
$22M19 mo ago1252002Bill Clinton
Co-Founder
WordPressMySQLPHP+32—2 job openings · 1 partnership
26Meadowhawk Biolabs
CRO focused on providing of drug discovery, pharmacology, and bioanalytical services
$20M23 mo ago352021—WordPressApple iCloud MailMicrosoft 365+25——
27Xsphera Biosciences
Developer of tumor preservation platform
$20M48 mo ago232018Steve Remondi
Co-Founder & CEO
——1 launch
28Nexcure
Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers
$19M3 mo ago—2026Anish More
Co-Founder & CBO
———
29Dash Bio
Provider of automated bioanalysis platform for accelerated clinical drug development
40Talent top 38%Funding top 39%Global bottom 33%
All 3 signals ▾
Talenttop 38%
Fundingtop 39%
Globalbottom 33%
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $17.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr)
rank vs industry peers · Fliar Intelligence Index 40/100
$18M12 mo ago—2024Ander Tallett
Co-Founder & COO
———
30Curavit
Contract research organization that offers a complete suite of CRO services for decentralized clinical trials
$16M43 mo ago262019—WordPressMySQLPHP+29——
31Biosim
Provider of contract based drug discovery services
$12M28 mo ago342020————
32Carna Health
Company that provides integrated point-of-care testing solutions and AI-powered technology
$11M5 mo ago—2021Salvatore Viscomi
Co-Founder & CEO
WebflowYouTubeMicrosoft Advertising+12—1 award
33Pepper
Provider of services for drug discovery and development services
$11M30 mo ago92021Jon Hu
Co-Founder
—2 patents
Corporate e‑learning platforms with gamified, group‑based training and assessment tools
—
34123 See
Retailer of health and personal care products
$8M25 mo ago—2020Matthias Hofmann
Co-CEO
———
35Leuko
Manufacturer of WBC monitoring device
$7M22 mo ago152017Carlos Gonzalez
Co-Founder & CEO
—15 patents
Non‑invasive optical capillary imaging for automated white blood cell detection and classification
—
36Lifordi
Biotechnology company developing treatments for autoimmune and inflammatory disorders using antibody-drug…
45Funding top 45%Talent bottom 49%Global bottom 36%
All 3 signals ▾
Fundingtop 45%
Talentbottom 49%
Globalbottom 36%
Funding: Raised $5.9M across 2 rounds · 2 rounds over 3 yrs (0.7/yr)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
rank vs industry peers · Fliar Intelligence Index 45/100
$6M6 mo ago—2023Arthur Tzianabos
CEO
———
37MAKScientific
Targeting the endocannabinoid system for the treatment of metabolic disorders, pain, addiction, and…
$6M13 mo ago—2004Alexandros Makriyannis
Co-Founder
—22 patents
Therapeutic small‑molecule drugs and formulations for addiction, cannabinoid toxicity, and fibrosis
—
38Boston Cell Standards
Manufacturer of IHC testing products
$5M16 mo ago62003Steve Bogen
Co-Founder & President & CEO
———
39Alleviate
Manufacturer of plantar fasciitis systems
$4M29 mo ago82020Roderick McMullen
Co-Founder
PageFlyUnbounceCart Functionality+367 patents
Therapeutic foot orthoses and massage devices for chronic pain relief
—
40FamilyWell Health
Provider of integrated perinatal mental health services for OB clinics.
45Growth top 28%Funding top 41%Tech top 50%Talent bottom 49%
All 7 signals ▾
Growthtop 28%
Fundingtop 41%
Techtop 50%
Talentbottom 49%
Moatbottom 38%
Globalbottom 29%
Marketbottom 27%
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $4.3M across 2 rounds · 2 rounds over 2 yrs (1.0/yr)
rank vs industry peers · Fliar Intelligence Index 45/100
$4M7 mo ago—2022Jessica Gaulton
Founder & CEO
Cart FunctionalitySquarespace CommerceSquarespace+19——
41Guided Clinical Solutions
Provider of patient outcomes and guided clinical solutions
$3M12 mo ago22022Karen Nanji
Co-Founder
———
42Centering Healthcare Institute
Provider of patient education services
$3M14 mo ago37
37 → 54 (+46%)
2001Sharon Schindler Rising
Founder
Cart FunctionalityCraft CMSApple iCloud Mail+23—1 partnership
43Atalan
Provider of healthcare tracking solution and machine learning based turnover prediction services
$3M32 mo ago82021Bart Blackburn
Co-Founder & CSO
WordPressApple iCloud MailGoogle Workspace+22—1 launch
44Zip Run
Online platform for THC and CBD products
$3M32 mo ago62020—WordPressMySQLPHP+16——
45Connective Health
Provider of clinical quality measurement, risk adjustment scores, and health plan services
$2M20 mo ago102021—WordPressApple iCloud MailGoogle Workspace+22——
46AxmedRx
Manufacturer of drugs
$2M25 mo ago—2023Sofia Radley-Searle
Co-Founder
———
47EMBioSys
Developer of non-invasive wearable technology for induced electric field cancer therapy
$2M6 mo ago—2022Vish Subramaniam
Co-Founder & CSO
———
48Surgicure Technologies
Manufacturer of breathing tubes and other medical devices
9Funding top 44%Talent bottom 49%Global bottom 36%News bottom 18%
All 5 signals ▾
Fundingtop 44%
Talentbottom 49%
Globalbottom 36%
Newsbottom 18%
Marketbottom 11%
Funding: Raised $1.7M across 3 rounds · 3 rounds over 2 yrs (1.5/yr)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
rank vs industry peers · Fliar Intelligence Index 9/100
$2M15 mo ago42018Irena King
Founder & CEO
——1 launch · 2 partnerships · 4 awards
49PHI
Manufacturer of holographic imaging devices
$1M20 mo ago142004—WordPress Block EditorWordPressMySQL+10——
50Ayana Bio
Manufacturer of nutritional supplements
$1M14 mo ago132021Frank Jaksch
CEO
——2 awards

Top 12 Healthcare companies in Boston

#1
Series B · Boston, Massachusetts · founded 2014 · 4 employees
$90.2Mraised
▾

Imbria Pharmaceuticals provides therapeutics solution by translation the cellular metabolism. It is involved in providing transformative medicine, by altering the cellular metabolism and mitochondrial function.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers
Funding rounds
  • Nov 2025Series B—
  • Mar 2025Series B$66.7M
  • Jul 2019Series B$50M
  • Jul 2018Series B$40.2M
Founders & team
David-Alexandre GrosCo-Founder & CEOAndrew LevinCo-Founder
Investors
RA Capital Management, Sanofi Ventures, Deep Track Capital, AN Venture Partners, Catalio Capital Management, Cytokinetics
#2
Series A · Boston, Massachusetts · founded 2022
$153Mraised
▾

Superluminal Medicines Inc. is a biotechnology research company based in Boston, Massachusetts. They specialize in generative biological and chemical solutions for drug discovery programs. The company recently launched with a $33 million seed round to fuel its drug discovery engine and pipeline of small molecule therapeutics.

Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 21%
Talent
top 38%
Market
bottom 44%
Partners
bottom 35%
Global
bottom 29%
News
bottom 15%
Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series A (Aug 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Market: 1 contract event in 12 mo
Audience (LinkedIn): 5k LinkedIn followers
Activity (LinkedIn): 1 partnerships · 1 awards (incl. Eli Lilly & Company) announced in 12 mo
Funding rounds
  • Aug 2025Series A$5M
  • Aug 2024Series A$120M
  • Aug 2023Seed$33M
Founders & team
Ajay YekkiralaCo-FounderCony DcruzCo-Founder & CEO
Investors
RA Capital Management, Nvidia, Insight Partners, Gaingels, Catalio Capital Management, Lilly
#3
Series A · Boston, Massachusetts · founded 2026
$19Mraised
▾

Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers. The organization builds and operates treatment facilities in partnership with health systems. It aims to expand access to advanced therapeutics by developing innovative outpatient centers. The platform integrates patient selection, remote monitoring, and standardized clinical protocols.

Funding rounds
  • Mar 2026Series A$19M
Founders & team
Anish MoreCo-Founder & CBOSophie PapaCo-Founder & CMOPaul RothmanCo-Founder
Investors
RA Capital Management, Cencora, Oncology Ventures
#4
Series B · Boston, Massachusetts · founded 2018 · 18 employees
$68.3Mraised
▾

Manufacturer of diagnostic test devices

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: Corporate Controller, Scientist, Development
Activity: 2 product launches announced in 12 mo
Funding rounds
  • Sep 2025Series B$59M
  • Apr 2023Series A$41M
  • Jan 2021Series A$27.3M
Founders & team
Joseph SedlakCo-Founder & CSO
Investors
Novalis LifeSciences, Sozo Ventures, Hatteras Venture Partners, iSelect Fund, cancer.org.uk, Broadway Angels
#5
Series A · Boston, Massachusetts · founded 2021
$11.4Mraised
▾

Company that provides integrated point-of-care testing solutions and AI-powered technology

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
  • Jan 2026Angel$8M
  • Jan 2025Series A$3.4M
Founders & team
Salvatore ViscomiCo-Founder & CEOBoris BeratCo-Founder & CTPO
Tech stack
CloudflareCookiebotGoogle Font ApiGoogle Hosted LibrariesHstsHttp/3
#6
Series B · Boston, Massachusetts · founded 2018
$28.8Mraised
▾

Grouper is a social fitness benefit offered by health plans that pays members to have fun with their social groups or clubs. It covers annual group or club membership dues and provides a catalog of clubs to explore and join based on zip code.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Funding rounds
  • Sep 2025Series B$2.9M
  • Oct 2024Series B$18.6M
  • Jul 2023Series A$10.2M
  • 2018Seed—
Founders & team
Spencer MorganFounderDouglas WennersCEO
Investors
Sorenson Impact Foundation, New Enterprise Associates, Magnify Ventures, Fordcastle
Tech stack
Amazon Web ServicesApple Icloud MailBackbone.JsCloudflareCloudflare Bot ManagementCloudflare Browser Insights
#7
Seed · Boston, Massachusetts · founded 2023
$5.9Mraised
▾

Lifordi is a biotechnology company that develops treatments for autoimmune and inflammatory disorders using antibody-drug conjugates. They have experienced leadership in drug development, immunology, and inflammatory disorders. Lifordi Immunotherapeutics is led by CEO Arthur Tzianabos.

Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 45%
Talent
bottom 49%
Global
bottom 36%
Funding: Raised $5.9M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) · Last round Seed (Nov 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Investors from 1 country beyond United States
Funding rounds
  • Nov 2025Seed—
  • Sep 2025Grant (prize money)$3M
  • Jun 2023Grant (prize money)$3M
Founders & team
Arthur TzianabosCEO
Investors
HHS, Sanofi Ventures, Arch Venture Partners, 5AM Ventures, Atlas Venture
#8
Series A · Boston, Massachusetts · founded 2022
$4.3Mraised
▾

{}

Fliar Intelligence Index™ 45how this company ranks against its industry peers
Growth
top 28%
Funding
top 41%
Tech
top 50%
Talent
bottom 49%
Moat
bottom 38%
Global
bottom 29%
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $4.3M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Nov 2025)
Tech: 22 technologies across 4/8 capability areas · Observability: Sentry · Security: Hsts
Audience (LinkedIn): 8k LinkedIn followers
Funding rounds
  • Nov 2025Series A$8M
  • Feb 2024Seed$4.3M
Founders & team
Jessica GaultonFounder & CEO
Investors
.406 Ventures, Grey Matter, Mother Ventures, New Markets Venture Partners, GreyMatter, The DONNA Foundation
Tech stack
AngularApple Icloud MailCart FunctionalityCore-JsGodaddyGoogle Analytics
#9
Series A · Boston, Massachusetts · founded 2024
$17.5Mraised
▾

Provider of automated bioanalysis platform for accelerated clinical drug development. It leverages AI and robotics to deliver high-quality assays with faster turnaround times for clinical trials and GLP studies. The company automates critical steps in bioanalysis, reducing costs and time to market. It focuses on clinical bioanalysis, specifically the testing of samples from clinical trial subjects. The platform integrates quality, automation, and regulatory compliance to enhance customer experience and outcomes.

Fliar Intelligence Index™ 40how this company ranks against its industry peers
Talent
top 38%
Funding
top 39%
Global
bottom 33%
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $17.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Jun 2025)
Global: Single-market focus (United States)
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
  • Jun 2025Series A$11M
  • Oct 2024Seed$6.5M
Founders & team
Ander TallettCo-Founder & COODave JohnsonCo-founder & CEO
Investors
Freestyle, Swift Ventures, Life Extension Ventures, The Aligned Fund, Cybernetix Ventures, Drive Capital
#10
Series B · Boston, Massachusetts · founded 1987 · 335 employees
$25Mraised
▾

Provider of health care services intended to provide quality health care globally to those who need it most. The company operates a nonprofit organization that provides preferential options for the poor and marginalized individuals in the healthcare sector, enabling patients to meet their physical, mental, emotional, and daily needs so that they can recover from illness and maintain good health.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 146k LinkedIn followers — 20.9% of this cohort's audience
Funding rounds
  • Feb 2025Grant (prize money)$20.6M
  • 2023Grant (prize money)—
  • Oct 2022Series B$25M
  • 2021Grant (prize money)$11.2M
Founders & team
Ophelia DahlCo-FounderTodd MccormackCo-Founder
Investors
Weiss Asset Management, HRSA, HHS, USAID, Preston Werner Ventures
Tech stack
AdrollAdroll Cmp SystemAmazon AlbAmazon Web ServicesApache Http ServerAzure
#11
Series B · Boston, Massachusetts · founded 2019 · 20 employees
$34Mraised
▾

R&D company focused on manufacturing drugs for multiple therapeutic areas

Funding rounds
  • Jan 2025Series B$6.5M
  • Nov 2024Series B$4M
  • Jul 2022Series B$34M
Founders & team
Philip AustinCo-founder and Member of Board of Directors
Investors
Novalis LifeSciences, Anterra Capital, Finistere Ventures
#12
Acquired · Boston, Massachusetts · founded 2018 · 3 employees
$36.9Mraised
▾

Provider of cancer drugs development services

Funding rounds
  • Dec 2024Grant (prize money)$35.5M
  • Sep 2024Grant (prize money)$1.4M
Founders & team
Anne AltmeyerCEO
Investors
National Cancer Institute, Arpa H, HHS, Global BioAccess, BioGeneration Ventures, Civilization Ventures

Funding & investor landscape

$3.2Btotal disclosed funding
83companies funded
238disclosed rounds
1rounds last 90 days
Most active investors
HHS29 rounds
MassChallenge8 rounds
RA Capital Management8 rounds
HRSA4 rounds
NIH4 rounds
Orbimed4 rounds
.406 Ventures3 rounds
Arch Venture Partners3 rounds
Avestria Ventures3 rounds
BVF Partners3 rounds

Notable founders

David-Alexandre Gros
Co-Founder & CEO · Imbria Pharmaceuticals
Andrew Levin
Co-Founder · Imbria Pharmaceuticals
Ajay Yekkirala
Co-Founder · Superluminal Medicines
Cony Dcruz
Co-Founder & CEO · Superluminal Medicines
Anish More
Co-Founder & CBO · Nexcure
Sophie Papa
Co-Founder & CMO · Nexcure
Joseph Sedlak
Co-Founder & CSO · Mercy BioAnalytics
Salvatore Viscomi
Co-Founder & CEO · Carna Health
Boris Berat
Co-Founder & CTPO · Carna Health
Spencer Morgan
Founder · Grouper
Douglas Wenners
CEO · Grouper
Arthur Tzianabos
CEO · Lifordi
Prism market signals · United States · country-scoped Prism corpus, 13,358,462 docs

Market landscape — 10 sub-themes by coverage

Share of Healthcare coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

Common questions

How many Healthcare companies are there in Boston, United States?
Radar tracks 314 indexable Healthcare companies headquartered in Boston, United States that meet our profile-completeness bar.
What is the total funding raised by Healthcare companies in Boston, United States?
The Healthcare companies in Boston, United States on this list have raised a combined $3.2B in disclosed equity funding across 83 funded companies.
Which is the highest-funded Healthcare company in Boston, United States?
Ziopharm Oncology is the highest-funded Healthcare company in Boston, United States, with $376.6M in disclosed equity funding.
How many Healthcare companies in Boston, United States are funded?
83 of the 314 Healthcare companies in Boston, United States on this list have disclosed at least one equity funding round.
How many Healthcare unicorns are there in Boston, United States?
None of the Healthcare companies in Boston, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Boston, United States Healthcare companies?
The most active investors in Boston, United States Healthcare companies on this list include HHS, MassChallenge, RA Capital Management, HRSA, NIH.
Riya SenguptaFinancials

Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.

Coming soon